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The usefulness of a pectoralis major myocutaneous flap in 
preventing salivary fistulae after salvage total laryngectomy
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Salvage laryngectomy in patients treated with organ preservation protocols is associated with 
high rates of postoperative complications. The use of non-irradiated tissue flaps in pharyngeal 
reconstruction could reduce the incidence of these complications.
Objective: This study aims to evaluate the usefulness of the pectoralis major myocutaneous flap 
in preventing salivary fistulae during the postoperative period of salvage total laryngectomy (TL).
Materials and Method: This retrospective study enrolled 31 patients operated between April of 
2006 and May of 2011. All patients had advanced cancer at the time of the salvage procedure and 
had been treated with chemoradiotherapy or radiotherapy alone. Pharyngeal reconstruction was 
performed using pectoralis major myocutaneous flap in 19 cases (61%); primary wound closure 
occurred in 12 patients (39%).
Results: Salivary fistulae occurred in 16% of the patients who received the flap and in 58% of the 
patients with primary closure of the pharynx (p < 0.02). No statistically significant differences were 
noted between the groups with respect to the mean time for fistula formation, reintroduction of an 
oral diet, or use of a nasoenteric tube for feeding.
Conclusion: The pectoralis major myocutaneous flap was found to reduce the incidence of salivary 
fistulae in salvage laryngectomy procedures.
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INTRODUCTION
The treatment of head and neck squamous cell 
carcinoma (SCC) has changed substantially in the last few 
years1. The development of organ preservation protocols 
and primary chemoradiotherapy (CRT) for a subgroup of 
patients with advanced laryngeal cancer resulted in organ 
preservation rates of 64% and global survival similar to 
the levels seen in patients offered laryngectomy followed 
by radiotherapy, a treatment then considered the standard 
for this type of cancer2-4.
Despite the efficacy of chemoradiotherapy, a con-
siderable number of patients still require salvage surgery 
- usually in the form of total laryngectomy - when the 
disease persists or recurs5,6. However, a number of stu-
dies have shown high complication rates associated with 
salvage laryngectomy due to the effects of radiotherapy 
combined with chemotherapy upon wound healing3,7. 
More specifically, pharyngocutaneous fistulas - the most 
common post-laryngectomy complication - occur more 
frequently in this population and may affect more than 
50% of the patients8. This complication leads to increased 
morbidity, prolonged hospitalization, and greater hospital 
care expenditure9,10. The same happens to patients with 
early recurring laryngeal tumors after radiotherapy alone5,6.
In an attempt to prevent or reduce the incidence 
of salivary fistulas, some authors have advocated the 
routine use of non-irradiated tissue to reinforce and close 
the larynx. Candidate tissues range from pectoralis major 
myocutaneous flaps, sternocleidomastoid muscle collar 
flap, to microvascular flaps2.
This study aims to assess the use of pectoralis ma-
jor myocutaneous flaps to close the pharynx in patients 
submitted to therapy with chemotherapy and/or radiothe-
rapy followed by total laryngectomy (TL) or salvage total 
pharyngolaryngectomy (TPL) and compare the incidence 
of salivary fistulas in flap and primary pharyngeal closure 
patients.
MATERIALS AND METHODS
This retrospective study included the charts of pa-
tients diagnosed with relapsing squamous cell carcinoma 
(SCC) after primary treatment with radiotherapy alone or 
radiotherapy combined with chemotherapy seen from 
April of 2006 to May of 2011. All patients underwent TL 
or salvage TPL followed by primary pharyngeal closure 
or placement of a pectoralis major myocutaneous flap to 
repair the pharyngeal tract. The choice of using the flap 
or not was not randomized and was based on the intrao-
perative preference and judgment of the surgeon.
This study was approved by the Ethics Committee 
on April 5, 2010 and granted permit # 0584.1.203.000-09.
The following parameters were compared: primary 
pharyngeal closure and repair with pectoralis major myo-
cutaneous flap, index and mean time until the appearance 
of a salivary fistula, use of nasoenteral feeding tube, time 
until reintroduction of oral feeding. Previous tracheostomy 
was also investigated as a possible predisposing factor for 
the formation of salivary fistulas.
Only patients with primary tumors located in the 
larynx or hypopharynx, with failed treatment after che-
motherapy and/or primary radiotherapy, and submitted to 
TL or TPL were included in the study. Patients submitted 
to partial laryngectomy, partial base of tongue resection 
were excluded.
Statistical analysis was done with software package 
SPSS release 13.0; all tests considered a level of statistical 
significance of 5%.
RESULTS
Thirty-one patients with relapsing or residual SCC in 
the larynx or hypopharynx were operated. The diagnosis 
was confirmed through pathology tests.
Patient mean age was 65.5 years (43-84 years). Data 
on gender, nutritional status, and previous tracheostomy 
can be seen on Table 1.
Table 1. Patient clinical characteristics (n = 31).
Variables n %
Gender
Male 30 97.0
Female 1 3.0
Previous tracheostomy
Yes 17 55.0
No 14 45.0
Nutritional status
Eutrophic 8 25.0
Mild malnutrition 6 19.0
Moderate malnutrition 1 3.0
Not informed 22 31.0
The most frequent comorbidity was high blood 
pressure, seen in 19% of the patients. Other comorbidities 
were: chronic liver and coronary disease 6%, heart disease 
3%. Sixty-six percent (22/31) of the patients had incomplete 
data on their associated comorbidities.
Primary tumor locations can be seen on Table 2.
Patient staging according to the TNM classification 
of malignant tumors can be seen on Table 3.
Twenty-three percent of the patients (7/31) 
underwent pharyngolaryngectomy and 77% (24/31) 
were submitted to total laryngectomy. The neck was 
surgically approached in 33% of the patients the following 
way: radical bilateral neck clearance in 3% of the cases, 
unilateral radical neck clearance in 3% of the patients, 
bilateral jugular clearance in 18% of the cases, radical 
clearance on one side and jugular clearance on the other 
side in 3%, selective clearance of levels II-III in 3%, and 
in 6% of the patients there was no information on their 
charts. No type of clearance was performed in 61% of the 
patients (Table 4).
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Table 2. Primary tumor site (n = 31).
Tumor site n %
Supraglottis 2 6.0
Glottis 13 43.0
Subglottis 1 3.0
Transglottis 8 25.0
Hypopharynx 7 23.0
Table 3. Patient TNM11 staging (n = 31).
Staging n %
T
T3 10 31%
T4 22 69%
N
N0 24 75%
N1 5 15%
N2 1 3%
N3 2 6%
Table 4. Treatment offered.
Variables n %
Type of surgery
Total laryngectomy 24 77.0
Total pharyngolaryngectomy 7 23.0
Pharyngeal 
reconstruction
Pectoralis flap 19 61.0
Primary closure 12 39.0
Neck clearance
Radical bilateral 1 3.0
Radical unilateral 1 3.0
Jugular bilateral 6 18.0
Radical + jugular 1 3.0
Superselective 1 3.0
None 19 61.0
Pharyngeal reconstruction was performed with 
pectoralis major myocutaneous flap in 61% (19/31) of the 
cases, while primary pharyngeal closure was done in 39% 
(12/31) of the patients.
In terms of postoperative complications, the ove-
rall incidence of salivary fistulas was 32% (10/31). Fifty-
-eight percent (7/12) of the patients submitted to primary 
pharyngeal closure had salivary fistulas. Sixteen percent 
(3/19) of the myocutaneous flap patients had pharyngo-
cutaneous fistulas (p < 0.02). There was no difference on 
the incidence rates of fistulas when the following variables 
were compared: T and N staging; tumor location. There 
was a trend for lower incidence rates among eutrophic 
patients when compared to patients with some degree of 
malnutrition (p = 0.09) (Tables 5 and 6).
Five in 17 (29%) patients submitted to previous tra-
cheostomy and salvage laryngectomy had salivary fistulas, 
while four in 12 (33%) of the patients without previous 
tracheostomy had salivary fistulas (p = 0.56).
Table 5. Salivary fistula incidence: comparison between pec-
toralis major flap and primary closure.
Variables Pectoralis major flap Primary closure Total p
Salivary 
fistula
Yes 3 7 10
0.02
No 16 5 21
Total 19 12 31
Table 6. Comparison between types of pharyngeal closure in 
relation to time of use of NET, reintroduction of oral feeding, 
and appearance of salivary fistula (n = 31).
Variables Pectoralis 
major flap
Primary 
closure p
Mean time on NET* 24.6 23.7 0.47
Mean time until reintroduction of oral 
feeding 19.3 14.4 0.8
Mean time to fistula appearance 12.6 9.5 0.47
* NET = nasoenteral tube.
On the donor site, the surgical wound was affected 
by infection in 18% of the cases and hematoma in 10% of 
the patients. None of the patients had chyle fistulas, one 
patient had pneumonia and another died 35 days after 
surgery of pulmonary sepsis.
Likewise, when patients submitted to primary laryn-
geal closure and pectoralis major flap are compared, the 
mean time in days until the appearance of the fistula, the 
mean time of use of a nasoenteral tube, and mean time 
until the reintroduction of oral feeding were 9.5 and 12.6 
days (p = 0.47), 23.7 and 24.6 days (p = 0.47) and 14.4 
and 19.3 days (p = 0.80) respectively.
DISCUSSION
The development of organ preservation protocols 
with chemoradiotherapy has changed the treatment gi-
ven to patients with advanced laryngeal cancer. Aside 
from good local and regional control and survival rates 
similar to those seen in laryngectomy followed by radio-
therapy, this combination of therapeutical approaches 
has the additional benefit of sparing the organ, allowing 
many patients to maintain good voice quality and little 
or no dysphagia. Chemoradiotherapy programs have 
thus become the standard of care for the eligible patient 
subgroups1,2,5,12.
One of the consequences of this approach is the 
change on the role surgery plays in treating these patients. 
Surgery is no longer the primary therapy in these cases, 
and is being gradually reserved to treat cases of residual or 
relapsing tumors, when no other options are available1,2,5. 
Total laryngectomy (TL) and total pharyngolaryngectomy 
(TPL) are the standard salvage procedures after chemo-
radiotherapy, while partial laryngectomy is reserved for 
selected cases6.
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Despite the benefits of conservative treatments, 
salvage laryngectomy in patients treated with chemoradio-
therapy is associated with high postoperative complication 
rates13. Pharyngocutaneous fistulas are the most common 
complication, and usually occur within 7-10 days after 
surgery9. The incidence rates of salivary fistulas in this 
study was 32%, as also observed by other authors such as 
Varghese et al.14 - 41% and Putten et al.6 - 30%.
This complication may delay rehabilitation, adjuvant 
therapy15, and the reintroduction of oral feeding10, aside 
from increasing the length of hospitalization and care costs. 
Tsou et al.16 showed that the length of hospitalization of 
patients with pharyngocutaneous fistulas was 37.6 days, 
against 20.7 days for patients without fistulas.
Multiple risk factors for the formation of salivary 
fistulas have been described. Among them are T staging, 
associated comorbidities, neck clearance, pre and posto-
perative low levels of hemoglobin, low serum albumin, 
previous tracheostomy, type of closure, surgery time, 
and preoperative chemotherapy and radiotherapy5,7,10,15. 
In this study, most of these variables were not related to 
increased incidence rates of postoperative salivary fistulas. 
On a meta-analysis, Paydarfar & Birkmeyer15 showed that 
preoperative radiotherapy increases the risk of pharyn-
gocutaneous fistulas (RR, 2.28; p < 0.001), confirming the 
findings of other papers, in which fistula incidence rates 
ere higher in previously irradiated patients when compared 
to non-irradiated subjects as described by Ganly et al.12 
(32% versus 12%, p = 0.012 respectively). The effect of 
radiotherapy translates into injuries to tissue microvascu-
lature, resulting in myointimal fibrosis, endarteritis, and 
worsening of atherosclerosis, leading to a hypovascular, 
hypocellular, and hypoxic environment, reducing healing 
capacity, increasing the risk for fistula formation, its seve-
rity, and duration5,15,17.
The use of non-irradiated flaps has been recom-
mended to reduce the incidence rates and the morbidities 
associated with salivary fistulas in salvage laryngectomy 
patients, even when thee is enough mucosa for a primary 
closure procedure3,7. The rationale of this strategy revolves 
around using healthy tissue with abundant vascularization 
to maximize surgical wound healing, thus preventing local 
complications. Flaps have been used routinely in salvage 
laryngectomy procedures performed at head and neck 
surgery centers all over the world8.
Pectoralis major myocutaneous flaps have played 
an important role in head and neck reconstruction surgery 
since they were described by Ariyan in 1979. These flaps 
can be quickly fashioned, are viable and reliable, versati-
le in reconstruction procedures, located close to the site 
of resection, and allow the reconstruction to be done in 
one single procedure with low complication rates on the 
donor site18-20. When used in salvage laryngectomy, the 
myocutaneous flap may reduce salivary fistula incidence 
rates from 24% to 0% (p < 0.015), as shown by Patel & 
Keni8, and from 51% to 20% (p < 0.028) according to Ri-
ghini et al.21. In our study, the incidence of salivary fistulas 
in myocutaneous flap patients was 16%, while primary 
laryngeal closure patients had a salivary fistula incidence 
rate of 58%. Additionally, pectoralis major myocutaneous 
flaps seem to limit fistula severity and reduce the need for 
more surgery in patients with salivary fistulas2,7, although 
our study lacks the statistics to support this statement.
Similar results were achieved by Tsou et al.16, with 
reduced incidence rates of fistula in salvage pharyngola-
ryngectomy patients using radial forearm fasciocutaneous 
flaps.
As it is a regional flap, it does not require specific 
materials or teams specialized in microsurgical anastomo-
ses; and it introduces low donor site morbidity2,21.
Myocutaneous flaps could also reduce the risk of 
late complications such as stenosis, dysphagia, and use of 
feeding tubes as shown by Patel & Keni8; these findings 
were not observed in our study.
CONCLUSION
Pectoralis major myocutaneous flaps in the re-
construction of the pharynx of pharyngolaryngectomy 
or salvage total laryngectomy patients after chemo and 
radiotherapy may significantly reduce the incidence of 
salivary fistulas.
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